Image

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.

Eligibility

Inclusion Criteria (client participants):

  • English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs
  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures
  • Physically withdrawn from alcohol or other drugs

Inclusion Criteria (personnel participants):

  • English-speaking adults currently employed at one of the two outpatient addiction treatment programs
  • Provision of electronic informed consent

Exclusion Criteria (client participants):

  • Experiencing severe withdrawal symptoms
  • Actively psychotic, manic, and/or suicidal

Exclusion Criteria (personnel participants):

  • current position: facility owner or clinical director

Study details

Substance-Related Disorders, Treatment Adherence

NCT05489068

University of New Mexico

18 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.